COVID-19: Implications for Pharmacists: Round 2, What’s New?

When: Thursday, April 2, 2020
Time: 1:00PM - 2:00PM MST
Registration: FREE
Speakers: Meghan Jeffres, PharmD, BCIDP, Gina Moore, PharmD, MBA, Joseph Saseen, PharmD, BCPS, BCACP 

Developed by:

The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences

&

Colorado Pharmacists Society

Access

Live webinar: https://ucdenver.zoom.us/j/351593664  (Join early to ensure your device has required software)

Recording available within 24 hours at www.UCDenver.edu/pharmacy/continuingeducation

Learning Objectives (pharmacists & pharmacy technicians)

1.     Describe the relationship between NSAIDs and COVID-19.

2.     Summarize the cardiovascular implications of hydroxychloroquine use.

3.     Review the role of azithromycin in treatment of COVID-19.

4.     List the actions the Colorado Pharmacists Society has taken during the COVID-19 crisis.

Accreditation

The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE).  This activity has been accredited for 1.0 contact hours of knowledge-based CPE for pharmacists and pharmacy technicians.  To receive CPE, participants must create a profile on ipharmCE.UCDenver.edu with their NABP eProfile ID number and birthdate, and complete the activity evaluation.  CPE credit will be uploaded to CPE Monitor upon completion of the activity evaluation. 

UAN #0008-9999-20-015-L/H05-P/T                 

Release: 04/02/2020

Expire: 04/02/2023

Questions?:

Office of Practitioner Development

Email: [email protected]

Tel: (303) 724-4298

View PDF Flyer